1. >
  2. Investors
  3. >
  4. Regulated Information
  5. >
  6. Press Releases – Reg...

PRESS RELEASES

Found 307 Results
Page 1 of 31

Onxeo: report on the Extraordinary General Meeting of February 6, 2023


Paris (France), February 6, 2023 – 7:30 pm CET – Onxeo S.A. (Euronext Growth Paris: ALONX), (“Onxeo” or “the Company”), […]

02/06/2023


Onxeo Announces its Financial Agenda for 2023


Paris (France), January 27, 2023 – 6:00 pm CET – Onxeo S.A. (Euronext Growth Paris: ALONX), (“Onxeo” or “the Company”), […]

01/27/2023


ONXEO provides update on the Development Program for its first-in-class drug candidate AsiDNATM


Phase 1b/2 trial of AsiDNATM in combination with olaparib initiated in the United States in recurrent ovarian, breast and metastatic […]

01/25/2023


Onxeo advances its second lead candidate OX425 for the treatment of solid tumors


OX425 is a novel DDR Decoy Agonist which also mediates multiple immunostimulatory effects, making it a promising candidate for combination […]

11/30/2022


Onxeo Reports its Half-Year 2022 Financial Results and Provides an Update on its Activities


Refocusing R&D efforts as well as accelerating preclinical and clinical programs globally Cash position of €26.9 million as of June […]

09/13/2022


High-Grade Glioma Relapse in Children: Onxeo announces the enrollment of the first patient in the phase 1b/2 clinical study conducted by the European ITCC consortium and sponsored by Institut Curie


Paris (France), September 1st, 2022 – 8 pm CEST – Onxeo S.A. (Euronext Growth: ALONX, Nasdaq First North[1]: ONXEO), a […]

09/01/2022


Onxeo announces that Nasdaq approved the delisting of its shares from the First North Growth market in Copenhagen


Last day of trading on the First North Growth market on November 8, 2022 Listing on Euronext Growth Paris remains […]

08/30/2022


Combined General Meeting of August 17, 2022: Onxeo shareholders approve withdrawal from the Nasdaq First North market in Copenhagen


Company to submit delisting request to Nasdaq   Paris (France), August 17, 2022 – 08:00 pm CEST – Onxeo S.A. […]

08/17/2022


Combined General Meeting of August 17, 2022: availability of preparatory documents and participation & voting procedures


Paris (France), July 29, 2022 – 06:30 pm CEST – Onxeo S.A. (Euronext Growth: ALONX, Nasdaq First North: ONXEO), a […]

07/29/2022


Onxeo announces a Combined General Meeting on August 17, 2022


Paris (France), July 12, 2022 – 07:00 pm CEST – Onxeo S.A. (Euronext Growth Paris: ALONX, Nasdaq First North Copenhagen: […]

07/12/2022


Page 1 of 31